Non-clinical early signs on the potential of RNAi + IO combination: Silenseed to present in the “Annual Cancer Immunotherapy Summit” conference, November 21-22 2016, Berlin, (Title: RNAi And Immunotherapy – The Case Of Pancreatic Cancer); and in the “8th annual Conference on RNA Therapeutics 2017″, February 22-23, 2017, London (Title: RNAi and tumor microenvironment: pre-clinical and clinical evidence)